OSCR

MCC-135 Exerts Antiepileptic and Neuroprotective Effects by Downregulating NCX1 Expression to Decrease Intracellular Calcium Overload in the Hippocampus.

Overview

Authors: Chaoning Liu1, Min He1, Rida Li1, Shouhuan Zheng1, Lanfeng Sun1, Chi Gong1, Hengchang Qi1, Xinran Qin1, Xiaohang Gan1, Fang Wang1, Yuan Wu1
  1. Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China
Journal: CNS neuroscience & therapeutics, volume 32, issue 3, article e70808
Dates: received 15 September 2025; accepted 11 February 2026; published online 2 March 2026; in print March 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1002/cns.70808 · PMID 41772763 · PMCID PMC12953174 · OpenAlex W7133304661
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: mouse (organism), epilepsy (population), clinical / translational (subfield)
Methods: Smoothing, state filtering, decompositions
Keywords: calcium overload, epilepsy, glutamate release, MCC‐135, NCX1
MeSH: Anticonvulsants*, Calcium*, Epilepsy*, Hippocampus*, Neuroprotective Agents*, Sodium-Calcium Exchanger*, Animals, Down-Regulation, Male, Mice, Mice, Inbred C57BL, Neurons (* major topic)
Topic: Neuroscience and Neuropharmacology Research (Cellular and Molecular Neuroscience, Neuroscience), according to OpenAlex
Citations: not cited yet (Europe PMC); 45 references in the paper

Abstract

Background: Approximately 30% of epilepsy patients still develop drug resistance after standard antiepileptic treatment. Therefore, there is an urgent need to identify new drug targets to improve seizure control. Previous studies have shown that NCX1 can regulate the intracellular Ca2+ levels in astrocytes and neurons, which are closely associated with epilepsy. MCC‐135 has shown potential as an antiseizure medication due to its ability to downregulate NCX and reduce intracellular calcium overload; however, its role and mechanism in epilepsy remain unclear.

Methods: This study employed single‐cell analysis and molecular docking to identify the potential molecular targets of MCC‐135 in treating epilepsy. Additionally, we used a KA‐induced epileptic mouse model to validate these molecular levels and the therapeutic effects and mechanisms of MCC‐135.

Results: Relative to controls, NCX1 expression was significantly upregulated in the hippocampus of KA‐induced epileptic mice. Immunofluorescence staining revealed that NCX1 was co‐localized with both astrocytes and neurons. MCC‐135 treatment significantly prolonged the seizure latency in KA‐induced epileptic mice and alleviated hippocampal neuronal damage. Furthermore, MCC‐135 effectively reduced NCX1 expression, alleviated intracellular calcium overload, and downregulated glutamate levels in the epileptic mice.

Conclusion: MCC‐135 exerts neuroprotective and antiepileptic effects by downregulating NCX1 expression, thereby alleviating calcium overload and reducing glutamate levels in the hippocampus. We are the first to propose the role and mechanism of MCC‐135 in epilepsy treatment, providing novel insights into its potential as a therapeutic agent for epilepsy.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Other data links

Data Availability Statement

Data was downloaded from the public database online at the GEO database under accession numbers GSE160189 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE160189), GSE221849 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE221849), GSE241521 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE241521), GSE129308 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE129308), GSE157827 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE157827), GSE174367 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE174367), GSE178175 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE178175), GSE213364 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE213364), GSE140393 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE140393), GSE163737 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163737), GSE33000 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE33000), and GSE63808 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE63808).

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 11 authors, 5 keywords, 12 MeSH terms, 45 references.

Cite

This paper

Liu, C., He, M., Li, R., Zheng, S., Sun, L., Gong, C., Qi, H., Qin, X., Gan, X., Wang, F., & Wu, Y. (2026). MCC-135 Exerts Antiepileptic and Neuroprotective Effects by Downregulating NCX1 Expression to Decrease Intracellular Calcium Overload in the Hippocampus. CNS neuroscience & therapeutics, 32(3), e70808. https://doi.org/10.1002/cns.70808

BibTeX

@article{liu2026mcc,
author = {Liu, Chaoning and He, Min and Li, Rida and Zheng, Shouhuan and Sun, Lanfeng and Gong, Chi and Qi, Hengchang and Qin, Xinran and Gan, Xiaohang and Wang, Fang and Wu, Yuan},
title = {{MCC-135 Exerts Antiepileptic and Neuroprotective Effects by Downregulating NCX1 Expression to Decrease Intracellular Calcium Overload in the Hippocampus}},
journal = {CNS neuroscience \& therapeutics},
year = {2026},
month = mar,
volume = {32},
number = {3},
pages = {e70808},
publisher = {Wiley},
issn = {1755-5930},
doi = {10.1002/cns.70808},
url = {https://doi.org/10.1002/cns.70808},
pmid = {41772763},
pmcid = {PMC12953174}
}

RIS

TY - JOUR
AU - Liu, Chaoning
AU - He, Min
AU - Li, Rida
AU - Zheng, Shouhuan
AU - Sun, Lanfeng
AU - Gong, Chi
AU - Qi, Hengchang
AU - Qin, Xinran
AU - Gan, Xiaohang
AU - Wang, Fang
AU - Wu, Yuan
TI - MCC-135 Exerts Antiepileptic and Neuroprotective Effects by Downregulating NCX1 Expression to Decrease Intracellular Calcium Overload in the Hippocampus
T2 - CNS neuroscience & therapeutics
J2 - CNS Neurosci Ther
PY - 2026
DA - 2026/03/01
VL - 32
IS - 3
SP - e70808
SN - 1755-5930
PB - Wiley
DO - 10.1002/cns.70808
UR - https://doi.org/10.1002/cns.70808
LA - en
ER -

CSL-JSON

{
"id": "10.1002/cns.70808",
"type": "article-journal",
"title": "MCC-135 Exerts Antiepileptic and Neuroprotective Effects by Downregulating NCX1 Expression to Decrease Intracellular Calcium Overload in the Hippocampus",
"container-title": "CNS neuroscience & therapeutics",
"author": [
{
"family": "Liu",
"given": "Chaoning"
},
{
"family": "He",
"given": "Min"
},
{
"family": "Li",
"given": "Rida"
},
{
"family": "Zheng",
"given": "Shouhuan"
},
{
"family": "Sun",
"given": "Lanfeng"
},
{
"family": "Gong",
"given": "Chi"
},
{
"family": "Qi",
"given": "Hengchang"
},
{
"family": "Qin",
"given": "Xinran"
},
{
"family": "Gan",
"given": "Xiaohang"
},
{
"family": "Wang",
"given": "Fang"
},
{
"family": "Wu",
"given": "Yuan"
}
],
"container-title-short": "CNS Neurosci Ther",
"volume": "32",
"issue": "3",
"page": "e70808",
"DOI": "10.1002/cns.70808",
"PMID": "41772763",
"PMCID": "PMC12953174",
"ISSN": "1755-5930",
"publisher": "Wiley",
"URL": "https://doi.org/10.1002/cns.70808",
"language": "en",
"issued": {
"date-parts": [
[
2026,
3,
1
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3390/ijms27104466 [code]
Uncovering the Key Circuit FOSL2/FOS/EGR3/EGR1, Contributing to the Hyperexcitability of Excitatory Neurons in the Epileptic Temporal Cortex and Hippocampus.
Journal: International journal of molecular sciences
In common: NCBI GEO GSE160189, epilepsy, 2 references
[2] doi:10.1038/s41467-026-73796-5 [code]
Cross-species transcriptomic analysis of rodent model fidelity to human mesial temporal lobe epilepsy.
Journal: Nature communications
In common: epilepsy, mouse, 2 references
[3] doi:10.1159/000551068
Associations between Body Composition Patterns, Brain Diseases and Injuries, and Risk of Epilepsy: A Prospective Cohort Study.
Journal: Neuroepidemiology
In common: epilepsy, clinical / translational, 2 references
[4] doi:10.7554/elife.101859 [code]
On-demand seizures facilitate rapid screening of therapeutics for epilepsy.
Journal: eLife
In common: epilepsy, mouse, 2 references
[5] doi:10.1007/s10827-026-00924-x [code]
Astrocyte-induced dynamics of a pyramidal cell with a dendrite-connected astrocyte.
Journal: Journal of computational neuroscience
In common: epilepsy, 2 references
[6] doi:10.3389/fcell.2026.1793636
Pyroptosis in epilepsy: from pathophysiological mechanisms to therapeutic strategies.
Journal: Frontiers in cell and developmental biology
In common: epilepsy, 2 references
[7] doi:10.1038/s41586-026-10793-0
Cell-type signatures of Alzheimer's disease shared across population groups.
Journal: Nature
In common: 3 references
[8] doi:10.1073/pnas.2605750123
Light- and temperature-sensitive seizures are regulated by spatially distinct cortex glial populations in the central nervous system.
Journal: Proceedings of the National Academy of Sciences of the United States of America
In common: epilepsy, 2 references
[9] doi:10.1186/s12974-026-03951-8
Forkhead box versus NF-κB hippocampal snRNA-seq profiles distinguish anti-Drebrin- and anti-GAD65-positive encephalitis.
Journal: Journal of neuroinflammation
In common: epilepsy, mouse, 1 reference
[10] doi:10.1186/s40478-026-02282-2 [code]
The adhesion GPCR ADGRV1 controls glutamate homeostasis in hippocampal astrocytes supporting neurons.
Journal: Acta neuropathologica communications
In common: epilepsy, mouse, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.